Management of the conventional cardiovascular risk factors is insufficient to prevent the dramatic increase in atherosclerotic cardiovascular morbidity and mortality in patients with renal failure. Folate recently received attention as a potential alternative treatment option to decrease the excess
Is folate a promising agent in the prevention and treatment of cardiovascular disease in patients with renal failure?
β Scribed by De Vriese, An S. (author);Verbeke, Francis (author);Schrijvers, Bieke F. (author);Lameire, Norbert H. (author)
- Publisher
- Nature Publishing Group
- Year
- 2002
- Tongue
- English
- Weight
- 139 KB
- Volume
- 61
- Category
- Article
- ISSN
- 0085-2538
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract Preoperative administration of the simple bile salt sodium deoxycholate has been shown in this study to prevent postoperative endotoxaemia and renal failure in patients with obstructive jaundice. Fifty-four per cent of jaundiced patients not given the salt were found to have systemic en
cirrhosis. Chronic hepatitis B virus infection can also be asso-When renal lesions are suspected in patients with circiated with various patterns of renal disease, including memrhosis, clotting disorders often preclude percutaneous branous nephropathy, membranoproliferative glomerulonerenal biopsy.